AUG 6, 2026 · PHASE 3 TRIAL
Cardiovascular Protection After Preeclampsia With Enalapril
ClinicalTrials.gov
This is an active clinical trial registration with no reported results; the study is still recruiting and measures feasibility and retention rather than clinical efficacy.
Reported
Estimated enrollment60
Primary outcome measure 1Feasibility of enrollment, 4 months
Primary outcome measure 2Feasibility of retention, 4 months